Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Opioid Use Disorder

Opioid Use Disorder

Subtypes of Opioid Use Disorder

Opioid Overdose 8 Opioid dependence 2 Opioid Addiction 1 Prescription Opioid Misuse 0

29 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Opioid Use Disorder

202 trials tracked for Opioid Use Disorder: 45 in phase 3 or 4 and 23 with published results. The most-cited published study has 171 citations.

202Trials tracked
45Phase 3 & 4
0Recruiting
23With published results
Phase distribution
Phase 4 26 Phase 3 19 Phase 2 19 Phase 1 18 Other / NA 120
  1. Phase 3 Clinical Trial of Gabapentin to Decrease Postoperative Delirium and Pain Completed · 171 cited
  2. Phase 3 Long-Term Safety Study of Buprenorphine (CAM2038) in Adult Outpatients With Opioid Use Disorder Completed · 114 cited
  3. Phase 3 Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness Study Completed · 61 cited
  4. Phase 3 Does a Non-Opioid Multimodal Pain (NOMO) Protocol Decrease Narcotic Use Completed · 51 cited
  5. Phase 3 Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension) Completed · 49 cited
  6. Phase 4 Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment Completed · 48 cited
Show 44 more trials
  1. Phase 3 Non-Invasive Vagal Nerve Stimulation in Opioid Use Disorders Completed · 28 cited
  2. Phase 4 Pain Control Following Sinus Surgery Completed · 20 cited
  3. Phase 4 SUBLOCADE Rapid Initiation Study Completed · 16 cited
  4. Phase 4 Obstetric Liposomal Bupivacaine Via Surgical Transversus Abdominis Plane Block for Post Cesarean Pain Control Completed · 14 cited
  5. Phase 3 Open-Label Treatment Extension Study Completed · 13 cited
  6. Phase 3 Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder Completed · 13 cited
  7. Phase 3 Comparing Treatments for HIV-Infected Opioid Users in an Integrated Care Effectiveness Study (CHOICES) Scale-Up Completed · 13 cited
  8. Phase 3 Opioid Prescription After Cesarean Trial Completed · 11 cited
  9. Phase 4 Ketamine Versus Fentanyl for Surgical Abortions Completed · 9 cited
  10. Phase 4 The Impact of Perioperative Ketamine Infusion on Surgical Recovery Completed · 9 cited
  11. Phase 4 A Multimodal Analgesia Protocol Adapted for Ambulatory Surgery Completed · 8 cited
  12. Phase 4 Evaluation of Buprenorphine Extended-Release Subcutaneous Injection at Alternative Injection Locations Completed · 8 cited
  13. Phase 3 Evaluating Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Transitioning From Buprenorphine Maintenance Prior to First Dose of VIVITROL Completed · 8 cited
  14. Phase 4 Ketamine for Acute Pain Management After Trauma Completed · 7 cited
  15. Phase 4 The Effect of Pectoral Blocks on Perioperative Pain in Gender Affirmation Top Surgery Completed · 6 cited
  16. Phase 4 Prevention of Persistent Opioid Use in Mothers Completed · 5 cited
  17. Phase 4 Dronabinol in Total Knee Arthroplasty (TKA) Completed
  18. Phase 4 Ibuprofen and Acetaminophen Versus Ibuprofen and Acetaminophen Plus Hydrocodone for Analgesia After Cesarean Section Completed
  19. Phase 4 Opioid-Free Shoulder Arthroplasty Completed
  20. Phase 4 Gabapentin Regimens and Their Effects on Opioid Consumption Completed
  21. Phase 4 IV vs. Oral Acetaminophen as a Component of Multimodal Analgesia After Total Hip Arthroplasty Completed
  22. Phase 4 Improving Post-Operative Pain and Recovery in Gynecologic Surgery Completed
  23. Phase 4 Narcotics vs NSAIDs for Post-operative Analgesia in Outpatient Rhinoplasty Completed
  24. Phase 4 Prospective Effect of Intravenous Ketorolac on Opioid Use, EBL and Complications Following Cesarean Delivery Completed
  25. Phase 4 Rapid Initiation of Drug Treatment Engagement Completed
  26. Phase 4 Sofosbuvir/Velpatasvir in Postpartum Women With Opioid Use Disorder and Chronic Hepatitis C Infection Completed
  27. Phase 4 Buprenorphine Loading in the Emergency Department Completed
  28. Phase 4 Erector Spinae Plane Block Versus Conventional Analgesia in Complex Spine Surgery Completed
  29. Phase 4 The Impact of Sublingual Sufentanil on Postoperative Pain and Analgesic Requirements in Spine Surgery Patients Completed
  30. Phase 4 Optimizing Outpatient Anesthesia (OSPREy-Outpatient Surgery Pain Relief Enhancement) Completed
  31. Phase 4 Cannabidiol for Bilateral Total Knee Arthroplasty Completed
  32. Phase 3 Lorcaserin in Combination With XR-Naltrexone for Relapse Prevention in Opioid Use Disorder Completed
  33. Phase 3 Patient-Directed Postoperative Opioid Prescribing for Gynecologic Surgery Completed
  34. Phase 3 Minimally Invasive Thoracic Surgery Intercostal Nerve Block Trial Completed
  35. Phase 3 Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic Meniscus Surgery Completed
  36. Phase 3 Exparel Use in Adductor Canal Block After Total Knee Arthroplasty Completed
  37. Phase 3 A Strategy to Improve Success of Treatment Discontinuation in Buprenorphine Responders Completed
  38. Phase 3 Lidocaine Patches After Cesarean Section Completed
  39. Phase 3 Perioperative Pregabalin in Ureteroscopy Completed
  40. Phase 2 Impact of Lofexidine on Stress, Craving and Opioid Use Completed
  41. Phase 2 Integrated Outpatient Treatment of Opioid Use Disorder and Severe Injection Related Infections Completed
  42. Phase 2 A Study to Evaluate the Abuse Potential of Oxymorphone Compared to Other Mu Opioid Agonists. Completed
  43. Phase 2 Enhancing Medication-based Analgesia in Humans- STUDY 2 Completed
  44. Phase 2 Remote Observed Dosing of Suboxone to Improve Clinical Practice Completed

Showing the 50 most-cited and recently-updated of 202 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

What the trials found Updated — new results For clinicians

Opioid Use Disorder: what the trials found

New evidence indicates that cannabidiol was evaluated for its impact on cumulative opioid usage in the first 72 hours postoperatively 1. Additionally, Dronabinol 5mg Cap demonstrated no statistically significant differences in cumulative opioid consumption over 24-48 hours post-operatively 2, nor did it significantly impact time to discharge from physical therapy or average pain scores during ambulation 2.

Extended-Release Naltrexone was shown to result in specific scores for alcohol use and subacute withdrawal symptoms 21. Furthermore, OxyCODONE 5 Mg Oral Tablet was evaluated regarding Brief Pain Inventory (BPI) scores 22.

Recent results — preliminary, needs further review

  • • Buprenorphine combined with outpatient parenteral antibiotic therapy 3.
  • • Suvorexant (dual orexin receptor antagonist) 4.
  • • BIOPIN-6 Active Implant with Naltrexone 5.
  • • Marijuana, which showed varying results in self-administration of drug units 6.
  • • Steps 2 Change (S2C) 7.

For the clinician treating this condition

  • Dronabinol 5mg may be utilized postoperatively as it did not significantly increase opioid consumption or impact pain scores during ambulation compared to controls 2.
  • Ketamine administration is associated with a statistically significant difference in the occurrence of neuropsychiatric adverse events 15.
  • Self-Driven Repetitive Artmaking has been shown to significantly reduce patient anxiety, depression, and reported pain levels 14.

AI synthesis of 11 cited trials, updated Jun 21, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Pilot study examines salivary adiponectin receptor expression in opioid-exposed neonates
Pediatrics Cohort
Pilot study examines salivary adiponectin receptor expression in opioid-exposed neonates How does a mother's opioid use affect her baby's growth signals?
This observational pilot cohort compared salivary adiponectin receptor 1 expression and growth measurements in neonates born at ≥34 weeks' g…
Doctors are investigating how a mother's opioid use during pregnancy might change a newborn's growth signals and body fat levels.
Frontiers Apr 7, 2026
Naloxone prescriptions from US retail pharmacies increased substantially from 2012 to 2018
Infectious Disease
Naloxone prescriptions from US retail pharmacies increased substantially from 2012 to 2018 Did naloxone access improve? Pharmacy prescriptions more than doubled in one year
An observational report of naloxone dispensing trends in US retail pharmacies found the number of prescriptions increased substantially from…
Naloxone prescriptions at U.S. retail pharmacies more than doubled from 2017 to 2018, showing a major jump in access to this life-saving ove…
CDC Apr 6, 2026
Report estimates state-level economic costs of opioid use disorder and fatal overdose
Infectious Disease
Report estimates state-level economic costs of opioid use disorder and fatal overdose Report estimates state-level economic costs of opioid use disorder and overdose
A report estimated state-level economic costs of opioid use disorder and fatal opioid overdose in the United States.
A new report estimates the economic costs of opioid use disorder and fatal overdoses for every state in the United States in 2017.
CDC Apr 6, 2026
Report describes overdose education and naloxone distribution programs in U.S. syringe service programs
Infectious Disease
Report describes overdose education and naloxone distribution programs in U.S. syringe service programs How do syringe programs teach people to stop overdoses?
A report describes overdose education and naloxone distribution (OEND) programs within syringe service programs in the United States.
A new report looks at how syringe service programs across the U.S.
CDC Apr 6, 2026
In adult ED encounters, clinician engagement with EHR-based SDOH data was rare but higher in opioid use disorder cases
Emergency Medicine
In adult ED encounters, clinician engagement with EHR-based SDOH data was rare but higher in opioid use disorder cases Did reviewing social data in the ER actually change how doctors treated opioid use disorder patients?
This cross-sectional study of 17,103 adult emergency department encounters examined clinician engagement with electronic health record-based…
Doctors reviewed social data more often for opioid use disorder patients, yet this action did not increase medication treatments or fix raci…
medRxiv Apr 6, 2026
Analysis examines synthetic opioid and stimulant co-involved overdose deaths by occupations and industries
Infectious Disease
Analysis examines synthetic opioid and stimulant co-involved overdose deaths by occupations and industries Analysis looks at overdose deaths involving both opioids and stimulants across different jobs
An observational report analyzed synthetic opioid and stimulant co-involved overdose deaths across occupations and industries in the United …
A new analysis examines how different jobs and industries might connect to overdose deaths involving both synthetic opioids and stimulants.
CDC Apr 5, 2026
Pennsylvania report examines controlled substance prescribing patterns before fatal overdoses
Infectious Disease
Pennsylvania report examines controlled substance prescribing patterns before fatal overdoses What prescriptions did people have before dying from an overdose in Pennsylvania?
An observational report from Pennsylvania analyzed controlled substance prescribing patterns preceding fatal overdoses involving opioids, st…
A new Pennsylvania report maps the controlled substance prescriptions people received before dying from an overdose involving opioids or sti…
CDC Apr 5, 2026
Nitazene-related deaths reported in Tennessee field notes
Infectious Disease
Nitazene-related deaths reported in Tennessee field notes Health officials report nitazene-related overdose deaths in Tennessee
Field notes from Tennessee report nitazene-related deaths. The study type, population, and specific results were not reported. Clinicians sh…
Tennessee health officials warn that nitazenes, powerful synthetic opioids sometimes mixed with other drugs, are linked to recent overdose d…
CDC Apr 5, 2026
Protocol outlines target trial emulation for bipolar disorder treatments in patients with opioid use disorder
Psychiatry RCT
Protocol outlines target trial emulation for bipolar disorder treatments in patients with opioid use disorder Study protocol compares bipolar disorder medications for people with opioid use disorder
This protocol describes a planned target trial emulation study using population-level administrative data from British Columbia and Ontario,…
People with bipolar disorder and opioid use disorder face higher risks, but a new plan will compare how well different medications work for …
medRxiv Apr 4, 2026
Case series identifies 38 medetomidine-involved opioid overdoses in Chicago
Infectious Disease
Case series identifies 38 medetomidine-involved opioid overdoses in Chicago Chicago health officials identify overdoses involving veterinary sedative mixed with opioids
A case series in Chicago identified 38 individuals with medetomidine-involved opioid overdoses (12 confirmed, 26 probable).
Chicago officials warn that a veterinary sedative is now mixed with opioids in street drugs, causing 38 overdoses in the city.
CDC Apr 4, 2026
Case series describes possible severe withdrawal syndrome in 23 patients using illegal opioids in Pittsburgh
Infectious Disease
Case series describes possible severe withdrawal syndrome in 23 patients using illegal opioids in Pittsburgh Doctors report possible severe withdrawal in 23 patients using illegal opioids in Pittsburgh
A case series of 23 patients in Pittsburgh hospitals who used illegally manufactured opioids reported a possible severe withdrawal syndrome.
Doctors in Pittsburgh report 23 patients using illegal opioids experienced possible severe withdrawal, highlighting a potential risk that ne…
CDC Apr 4, 2026
Lifetime opioid overdose reported by 55% of pregnant individuals with OUD in buprenorphine treatment study
Anesthesiology & Pain Medicine RCT
Lifetime opioid overdose reported by 55% of pregnant individuals with OUD in buprenorphine treatment study What puts pregnant women with opioid addiction at highest risk for overdose?
A descriptive analysis of baseline data from a multisite RCT of 140 pregnant individuals with OUD receiving buprenorphine found 55% reported…
Pregnant women in opioid treatment face high overdose risk if they have used heroin, experienced trauma, or rely on others for money.
Apr 3, 2026

Questions about Opioid Use Disorder

Are there differences in newborn growth measurements for babies exposed to opioids in the womb?

Yes, babies exposed to opioids in the womb tend to have lower birth weight and smaller head circumference, with differences depending on the specific medication used.

Full answer →